The impact of legal cannabis availability on cannabis use and health outcomes: A systematic review-Reference-Cited by-同舟云学术

The impact of legal cannabis availability on cannabis use and health outcomes: A systematic review

Published:2023-06 Issue: Volume:116 Page:104039
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Manthey Jakob^ORCID,Jacobsen Britta,Hayer Tobias^ORCID,Kalke Jens,López-Pelayo Hugo^ORCID,Pons-Cabrera Maria Teresa^ORCID,Verthein Uwe,Rosenkranz Moritz

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference47 articles.

1. Geographical access to recreational marijuana;Ambrose;Contemporary Economic Policy,2021

2. Interrupted time series analysis of Canadian legal cannabis sales during the COVID-19 pandemic;Armstrong;Drug and Alcohol Review,2022

3. Rating the comparative efficacy of state-level cannabis policies on recreational cannabis markets in the United States;Blanchette;International Journal of Drug Policy,2022

4. Preliminary development of a brief cannabis use disorder screening tool: The cannabis use disorder identification test short-form;Bonn-Miller;Cannabis Cannabinoid Res,2016

5. U.S. cannabis legalization and use of vaping and edible products among youth;Borodovsky;Drug and Alcohol Dependence,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabis consumers’ preferences for legal and illegal cannabis: evidence from a discrete choice experiment;BMC Public Health;2024-09-04

2. Clinician perspectives on adolescent cannabis-related beliefs and behaviors following recreational cannabis legalization;Addictive Behaviors;2024-09

3. Germany's cannabis act: a catalyst for European drug policy reform?;The Lancet Regional Health - Europe;2024-07

4. Understanding youth and young adult cannabis use in Canada post-legalization: a scoping review on a public health issue;Substance Abuse Treatment, Prevention, and Policy;2024-06-17

5. The Development of Cannabinoids as Therapeutic Agents in the United States;Pharmacological Reviews;2024-06-07